MMP9 and liver dysplastic nodule: In Khokhar et al.’s (53) study, they showed MMP9 and PTEN to be the miR-21-5p targets in-silico analysis and suggested that metformin regulates MMP9 expression in T2DM and DN patient populations through hsa-miR-21-5p.